Myocardial performance index increases at long-term follow-up in patients with mild to moderate COVID-19.
Isa ArdahanliOnur AkhanEbru SahinOnur AkgunCihan DarcanPublished in: Echocardiography (Mount Kisco, N.Y.) (2022)
Our study showed that conventional diastolic function parameters were not affected in patients who survived COVID-19 with mild symptoms but had symptoms in the long term. However, MPI measurements showed left ventricular dysfunction. To our knowledge, this is the first echocardiographic follow-up study to evaluate left ventricular systolic and diastolic functions with MPI in COVID-19 patients. We think that when cardiac involvement assessment is required in patients who have survived COVID-19, MPI should be measured alongside other echocardiographic measurements.
Keyphrases
- left ventricular
- sars cov
- coronavirus disease
- hypertrophic cardiomyopathy
- left atrial
- cardiac resynchronization therapy
- heart failure
- mitral valve
- acute myocardial infarction
- aortic stenosis
- end stage renal disease
- ejection fraction
- respiratory syndrome coronavirus
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- oxidative stress
- sleep quality
- blood pressure
- coronary artery disease
- transcatheter aortic valve replacement
- patient reported outcomes
- pulmonary hypertension
- patient reported